Monovisc Drug Interactions: What to Avoid and What to Tell Your Doctor

Monovisc is an intra-articular medical device rather than a traditional systemic drug — which means its interaction profile is quite different from most medications. It doesn't enter your bloodstream in significant quantities, so the drug-drug interaction risks you might expect with oral medications are largely absent. However, there are specific agents, conditions, and practices that can affect how safely and effectively your Monovisc injection is administered. Here's everything you need to know before your appointment.

Does Monovisc Have Significant Drug-Drug Interactions?

Monovisc has no documented major drug-drug interactions with other orally or parenterally administered medications. Because it is injected directly into the joint and is not significantly absorbed systemically, it does not interact with medications that act through systemic mechanisms (blood thinners, heart medications, antidepressants, etc.) in the way a systemic drug would.

However, you should always tell your doctor and pharmacist about all medications you are taking — prescription, over-the-counter, vitamins, and supplements — before receiving Monovisc. Some interactions are indirect (e.g., medications that affect bleeding risk) and require clinical consideration even if they aren't pharmacokinetic drug-drug interactions.

The Most Important Interaction: Quaternary Ammonium Disinfectants

The one clinically significant interaction documented for Monovisc is with disinfectants containing quaternary ammonium salts (such as benzalkonium chloride). These are commonly used antiseptic skin preparations.

Quaternary ammonium compounds can cause precipitation of hyaluronate — essentially clumping the HA molecules in Monovisc, which would compromise the product's effectiveness and could introduce particulate matter into the joint.

This is a provider-side concern (your doctor's team should be using the correct antiseptic), but it's worth knowing. The skin preparation for Monovisc injection should use povidone-iodine or chlorhexidine gluconate — NOT products containing benzalkonium chloride or other quaternary ammonium antiseptics.

Medications That Increase Bleeding Risk

While not a direct drug interaction, medications that increase bleeding risk can complicate intra-articular injections. Monovisc is contraindicated in patients with known systemic bleeding disorders. Patients taking the following medications should discuss the timing and safety of their Monovisc injection with their provider:

Anticoagulants: Warfarin (Coumadin), apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa), edoxaban (Savaysa). These significantly increase bleeding risk at the injection site. Your provider may recommend timing the injection when anticoagulation is at its lowest level or briefly holding the medication (only with prescriber guidance).

Antiplatelet agents: Aspirin (especially high-dose), clopidogrel (Plavix), ticagrelor (Brilinta), prasugrel (Effient). These impair platelet function and can increase injection site bleeding.

NSAIDs: Ibuprofen (Advil, Motrin), naproxen (Aleve), diclofenac (Voltaren) — in high or chronic doses — have some antiplatelet effects and may affect the inflammatory response post-injection. Discuss with your provider whether to pause NSAIDs around the injection.

Corticosteroid Injections at the Same Time

Many providers are asked whether Monovisc and a corticosteroid injection can be given together in the same knee joint at the same visit. This is a complex clinical question. Some research suggests combining HA with corticosteroids can provide faster onset of relief (from the steroid) combined with longer duration (from the HA). However, the FDA has not specifically approved such combination use for Monovisc, and most payers require separate billing with documented medical necessity for combining agents in the same joint at the same visit.

Note: Monovisc's label states that it should not be used for a patient receiving corticosteroid injections in the same knee during the same course of viscosupplementation treatment, unless specific medical necessity exists. Always discuss this with your provider if you are considering a combined approach.

What to Tell Your Doctor Before Your Monovisc Injection

Bring or report the following information to your provider before your Monovisc appointment:

All medications: Include all prescription drugs, OTC medications, vitamins, and herbal supplements

Blood thinners: Specifically mention anticoagulants and antiplatelet agents so your provider can evaluate the bleeding risk and plan the injection timing accordingly

Allergies: Any known allergies to hyaluronate products, gram-positive bacterial proteins, or previous adverse reactions to knee injections

Current infections: Active skin infection, knee joint infection, or any systemic infection (Monovisc is contraindicated while these are present)

Pregnancy or breastfeeding: The safety of Monovisc during pregnancy and breastfeeding is unknown; discuss the risks and benefits with your provider

Venous or lymphatic stasis: If you have poor circulation in your leg, use caution — your provider should be aware of this before administering Monovisc

For more on Monovisc's side effect profile, see our Monovisc side effects guide. For a general overview of the medication, read what Monovisc is and what it treats.